MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma (Q39411400)

11 September 2017

MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma (English)

1 reference

11 September 2017

1 reference

1 reference

S I Rothschild

1

1 reference

11 September 2017

M P Tschan

2

1 reference

11 September 2017

E A Federzoni

3

1 reference

11 September 2017

R Jaggi

4

1 reference

11 September 2017

M F Fey

5

1 reference

11 September 2017

M Gugger

6

1 reference

11 September 2017

O Gautschi

7

1 reference

11 September 2017

language of work or name

English

0 references

publication date

16 January 2012

1 reference

11 September 2017

1 reference

11 September 2017

31

1 reference

11 September 2017

38

1 reference

11 September 2017

4221-4232

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.578

11 September 2017

0 references

cites work

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Sizing up miRNAs as cancer genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

MicroRNA-cancer connection: the beginning of a new tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Widespread microRNA repression by Myc contributes to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Id genes and proteins as promising targets in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

miRBase: microRNA sequences, targets and gene nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Mammalian microRNAs predominantly act to decrease target mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

21 January 2018

Human MicroRNA targets

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Phase II study of dasatinib in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Combinatorial microRNA target predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Id proteins at the cross-road of development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Integrin-regulated FAK-Src signaling in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

mir-29 regulates Mcl-1 protein expression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Expression profiling with RNA from formalin-fixed, paraffin-embedded material

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Src inhibitors in lung cancer: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Treatment for advanced tumors: SRC reclaims center stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Control of translation and mRNA degradation by miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

MicroRNAs in the pathogenesis of Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.578

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.578

1 reference

11 September 2017

1 reference